India Glycols Ltd (INDIAGLYCO)
₹273.40
Mkt cap
₹1,833 Cr
P/E ratio
5.78
P/B
0.62
Div yield
2.74%
ROE
11.30%
ROCE
12.40%
EPS (TTM)
₹47.30
Book value
₹438
52W range
164–273
Sector
Fast Moving Consumer Goods
Price history
Previous close
Established in 1988, India Glycols Ltd. is engaged in the manufacturing of green technology-based bulk, specialty & performance chemicals, and natural gums, spirits, industrial gases, sugar, and nutraceuticals. [1] [2]
NSE INDIAGLYCOBSE 500201
Health check
Constructive
ValuationCheap
ProfitabilityAverage
GrowthLow
TechnicalsBullish
52-week range
0.00% from high₹273
₹164+67.06% from low₹273
Current
₹273.40
Prev close
₹273.40
Day
0.00%
Price performance
1D
0.00%
1W
+21.53%
1M
+24.54%
3M
+40.53%
6M
+58.98%
1Y
+63.74%
YTD
+34.29%
Financials
Revenue, profit & margin
P/E ratio
5.8×
INDIAGLYCO is 85% below the sector median of 39.2×
INDIAGLYCO5.8×
Sector median39.2×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 689 | 775 | 904 | 926 | 969 | 961 | 975 | 863 | 1,040 | 1,092 | 1,102 | 976 | 1,130 | |
| Expenses | 589 | 679 | 802 | 822 | 843 | 845 | 852 | 717 | 891 | 935 | 927 | 810 | 961 | |
| Operating Profit | 100 | 96 | 102 | 105 | 126 | 116 | 124 | 146 | 150 | 158 | 175 | 166 | 170 | |
| OPM % | 15% | 12% | 11% | 11% | 13% | 12% | 13% | 17% | 14% | 14% | 16% | 17% | 15% | |
| Other Income | 12 | 12 | 9 | 10 | 14 | 15 | 19 | 13 | 20 | 14 | 3 | 14 | 21 | |
| Interest | 28 | 29 | 31 | 33 | 36 | 40 | 44 | 45 | 45 | 49 | 47 | 26 | 25 | |
| Depreciation | 21 | 28 | 26 | 26 | 28 | 28 | 27 | 33 | 34 | 38 | 41 | 41 | 42 | |
| Profit before tax | 64 | 50 | 54 | 56 | 76 | 63 | 71 | 82 | 91 | 84 | 91 | 112 | 123 | |
| Tax % | 20% | 24% | 23% | 24% | 20% | 22% | 20% | 22% | 19% | 22% | 25% | 23% | 21% | |
| Net Profit | 51 | 38 | 42 | 42 | 60 | 50 | 57 | 64 | 73 | 65 | 68 | 87 | 97 | |
| EPS in Rs | 8.25 | 6.13 | 6.71 | 6.81 | 9.74 | 8.02 | 9.16 | 10.33 | 11.81 | 10.51 | 10.09 | 12.97 | 14.45 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move +0.65% · closed higher next day 1 of last 1
| Q1FY27 | |
|---|---|
| Broadcast | 12 Aug '26◦ |
| Earnings day | +0.65% |
| +1 day | +1.11% |
| +5 days | +5.00% |
| +15 days | +16.78% |
| +30 days | — |
| Filing | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Results analysis
Shareholding
as of Jun 202659.63%Promoter
Promoters59.63%
FIIs2.24%0.03
DIIs5.21%0.02
Public32.91%
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| UNITDSPR | ₹1,440.00 | 56.52 | 1,04,739 | 1.18% | 463 | −20.54% | 2,708 | −10.36% | 26.39% |
| RADICO | ₹4,444.00 | 83.78 | 59,542 | 0.20% | 230 | +69.15% | 1,684 | +11.80% | 24.15% |
| UBL | ₹1,291.00 | 98.76 | 34,135 | 0.77% | 166 | −9.54% | 3,067 | +7.07% | 10.68% |
| ABDL | ₹600.00 | 75.24 | 16,783 | 0.90% | 45 | −12.98% | 979 | +6.08% | 18.38% |
| TI | ₹533.25 | 58.38 | 13,197 | 0.19% | 32 | −30.28% | 1,046 | +155.67% | 11.78% |
| PICCADIL | ₹617.95 | 43.35 | 6,091 | 0.16% | 21 | +16.33% | 251 | +17.42% | 18.01% |
| GLOBUSSPR | ₹895.10 | 28.01 | 2,816 | 0.73% | 26 | +49.05% | 789 | +12.71% | 11.25% |
| INDIAGLYCO | ₹273.40 | 5.78 | 1,833 | 2.74% | 97 | +32.19% | 1,130 | +8.64% | 12.40% |
| Median: 22 Co. | ₹299.42 | 39.19 | 1,332 | 0.24% | 22 | +16.23% | 260 | +11.80% | 12.40% |
Filings
Annual reports15
Annual Report 2026bseAnnual Report 2025bseAnnual Report 2024bseAnnual Report 2023bseAnnual Report 2022bseAnnual Report 2021bseAnnual Report 2020bseAnnual Report 2019bseAnnual Report 2018bseAnnual Report 2017bseAnnual Report 2016bseAnnual Report 2015bseAnnual Report 2014bseAnnual Report 2013nseAnnual Report 2013bse
Concall transcripts66
PPTSep 2026PPTSep 2026PPTSep 2026TranscriptSep 2026PPTSep 2026RECSep 2026PPTAug 2026TranscriptJun 2026PPTJun 2026RECJun 2026TranscriptFeb 2026PPTFeb 2026TranscriptNov 2025PPTNov 2025RECNov 2025TranscriptAug 2025PPTAug 2025PPTAug 2025TranscriptMay 2025PPTMay 2025RECMay 2025TranscriptFeb 2025PPTFeb 2025RECFeb 2025
Credit ratings6
Announcements5
Intimation Of Schedule Of Analyst / Institutional Investor Meeting. 7 Sep - India Glycols schedules non-deal roadshow in Mumbai on 10-11 September 2026.Material Update In Connection With Ennature Bio Pharma Limited With Reference To Observation Letter No. NSE/LIST/48932 Dated 17Th November, 2025 And No.
DCS/AMAL/TS/R37/3905/2025-26 Dated 19Th November, 2025 ("Observation Letters"), Issued By The National Stock Exchange Of India Limited And BSE Limited (Collectively The
"Stock Exchanges"), Respectively, Received In Relation To The Scheme Of Arrangement. 7 Sep - India Glycols shared a material update from Ennature Bio Pharma Limited, but detailsMaterial Update In Connection With IGL Spirits Limited With Reference To Observation Letter No. NSE/LIST/48932 Dated 17Th November, 2025 And No. DCS/AMAL/TS/R37/3905/2025-26 Dated 19Th November, 2025 ("Observation Letters"), Issued By The National Stock Exchange Of India Limited And BSE Limited (Collectively The "Stock Exchanges"), Respectively, Received In Relation To The Scheme Of Arrangement. 7 Sep - Company forwarded material updates from IGL Spirits Limited; details are in Annexure A, not iAnnouncement under Regulation 30 (LODR)-Investor Presentation 2 Sep - Please find attached for Chemical Business.Announcement under Regulation 30 (LODR)-Investor Presentation 2 Sep - Please find attached for Chemical Business.